sign in sign up
<<
Home , Laquinimod

Recherche in auf der Webseite www.clinicaltrials.gov zuletzt am 16.02.2016

47 studies found for: „systemic lupus erythematosus“ AND ““

Rank Status Study

1 Terminate Myfortic Versus in Systemic Lupus Erythematosus d Condition: Systemic Lupus Erythematosus Interventions: Drug: switch to Myfortic; Drug: contin

2 Completed Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) Conditions: Systemic Lupus Erythematosus; Athero Interventions: Drug: Mycophenolate mofetil; Drug: s

3 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Conditions: Systemic Lupus Erythematosus; SLE Interventions: Drug: Mycophenolate Mofetil; Drug: H oquine; Drug: Prednisone

4 Recruiting Trial of and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis Condition: Systemic Lupus Erythematosus, Lupus N Interventions: Drug: Oral prednisolone; Drug: Rituxim mofetil; Drug: Methyl prednisolone

5 Completed Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: laquinimod; Drug: Mycophenola roids; Drug: Placebo

6 Active, not Enteric-coated Mycophenolate Sodium Versus Azathioprine for the recruiting Extra-renal Lupus Manifestations Condition: Systemic Lupus Erythematosus Interventions: Drug: Azathioprine; Drug: Enteric- Coated Mycophenolate Sodium

7 Terminate Efficacy and Safety Study of to Treat Lupus Nephritis d Condition: Systemic Lupus Erythematosus Has Interventions: Drug: Corticosteroids (prednisone or Results prednisolone); Drug: Abatacept; Drug MMF)

8 Completed Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis Conditions: Systemic Lupus Erythematosus; Arthri Interventions: Drug: mycophenolate mofetil; Other: p late mofetil

9 Withdrawn Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) Condition: Systemic Lupus Erythematosus Interventions: Procedure: Leukapheresis; Procedure: immunosuppressive therapy conditionin Autologous CD34+HPC transplantation (HSCT); Procedure: Plasmapheresis; thymocyte globulin; Drug: Methylpred timulating factor (G- CSF); Drug: Corticosteroids; Drug: M athioprine; Drug: Intravenous immunog Drug: Rituximab; Drug:

10 Active, not A Study to Evaluate in Patients With Nephritis Due to recruiting Systemic Lupus Erythematosus (BELONG) Conditions: Lupus Nephritis; Systemic Lupus Eryth Interventions: Drug: corticosteroids; Drug: cyclophos te mofetil; Drug: ocrelizumab; Drug:

11 Recruiting ACTHar in the Treatment of Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: CellCept; Drug: Acthar gel

12 Completed A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects Has With International Society of Nephrology/Renal Pathology Society Results (ISN/RPS) 2003 Class III or IV Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: Rituximab; Drug: Placebo; Dru : Methylprednisolone; Drug: Diphenhy Drug: Prednisone

13 Recruiting Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) Conditions: Lupus Erythematosus; Graft-versus-ho Interventions: Drug: Cyclophosphamide; Drug: Sodiu mercapto ethane sulphonate; Drug: Flu : ; Drug: Mofetil; Drug: Ra

14 Terminate for the Treatment of Lupus Nephritis d Condition: Lupus Nephritis Has Interventions: Drug: Etanercept; Drug: Lupus Treatm Results Standard of Care; Drug: Placebo

15 Completed Effectiveness of Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76 Condition: Systemic Lupus Erythematosus Interventions: Drug: Belimumab 1 mg/kg; Drug: Beli Placebo

16 Active, not Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis recruiting Condition: Systemic Sclerosis Intervention: Drug: Belimumab

17 Completed Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) Condition: Systemic Lupus Erythematosus Intervention: Drug: paquinimod (ABR-215757)

18 Recruiting A Phase 2a, Efficacy and Safety Study of in Systemic Lupus Erythematosus Condition: Systemic Lupus Erythematosus Interventions: Drug: Ustekinumab IV; Drug: Placebo Drug: Ustekinumab SC; Other: Concom

19 Active, not + Very Low Tacrolimus vs Enteric-coated Mycophenolate recruiting Sodium + Low Tacrolimus in de Novo Renal Transplant Conditions: Transplantation Infection; Cytomegalo Interventions: Drug: Everolimus; Drug: Very Low Ta us; Drug: Steroids; Drug: Thymoglob late

20 Active, not Health-related Quality of Life Measure in Pediatric Lupus recruiting Conditions: Systemic Lupus Erythematosus; Qualit Intervention:

21 Unknown † Allogeneic Blood Stem Cell Transplantation for Patients With Life- Threatening Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Intervention: Procedure: Hematopoietic Cell Transp

22 Unknown † Cyclophosphamide in Lupus Nephritis Condition: Systemic Lupus Erythematosus Intervention:

23 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis Condition: Lupus Nephritis Interventions: Biological: Placebo plus standard thera Belimumab 10 mg/kg plus standard therapy; Drug: Standard therapy

24 Completed Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Has Results Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare Condition: Lupus Nephritis Interventions: Drug: Mycophenolate sodium; Drug: Prednisone; D rednisolone

25 Withdrawn Clinical Trial Treatment in Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: cyclosporine +mycophenolic aci enolic Acid + prednison

26 Completed Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis Condition: Lupus Nephritis Intervention: Drug: Mycophenolate mofetil

27 Terminated The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: mycophenolate sodium; Drug:

28 Completed A Study of Mycophenolate Mofetil (CellCept) in Management of Has Results Patients With Lupus Nephritis. Condition: Lupus Nephritis Interventions: Drug: Mycophenolate mofetil (MMF); Azathioprine; Drug: Placebo to Azat henolate mofetil; Drug: Corticosteroid

29 Completed Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: tacrolimus; Drug: mycophenola

30 Terminated A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Has Results Nephritis. Condition: Lupus Nephritis Interventions: Drug: Mycophenolate Mofetil; Drug: oprine; Drug: Cyclophosphamide

31 Completed Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis. Condition: Lupus Nephritis Interventions: Drug: Mycophenolate mofetil; Drug:

32 Recruiting Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: Tacrolimus; Drug: Mycopheno

33 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis Condition: Lupus Nephritis Intervention: Drug: Tacrolimus vs. Mycophenolate m Induction Therapy in Lupus Nephritis

34 Recruiting Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis Condition: Lupus Nephritis Interventions: Biological: BMS- 188667; Drug: Mycophenolate mofet cal: Placebo matching with BMS-1886

35 Terminated A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Has Results Patients With Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: Mycophenolate mofetil (MMF); enance Phase; Drug: Cyclophospham nisone

36 Recruiting The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear Condition: Lupus Nephritis Intervention: Drug: mycophenolic acid

37 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis Condition: Lupus Nephritis Intervention:

38 Terminated The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: MMF; Drug: Atacicept plus M

39 Completed A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis Conditions: Lupus Nephritis; Glomerulonephritis, Interventions: Drug: prednisolone and mycophenolate e and tacrolimus

40 Completed Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis Condition: Lupus Nephritis Intervention: Drug: low dose combination of MMF a

41 Completed Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V) Condition: Lupus Nephritis Intervention: Drug: Multitherapy

42 Terminated BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis Condition: Lupus Nephritis Interventions: Biological: BIIB023; Biological: Plac te Mofetil

43 Terminated Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil Condition: Lupus Nephritis Intervention: Drug: Atacicept

44 Completed Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: Multi-target therapy; Drug: Az

45 Recruiting A Study to Evaluate the Safety and Efficacy of , an Targeting Certain Types of Immune Cells, in Participants With Lupus Nephritis (LN) Condition: Lupus Nephritis Interventions: Drug: Mycophenolate Mofetil; Drug: acebo

46 Completed Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis Condition: Lupus Nephritis Interventions: Drug: Tacrolimus+Mycophenolate mo amide

47 Terminated BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis Condition: Lupus Nephritis Interventions: Biological: BIIB023; Drug: Backgrou